By
AmyT on
March 22, 2013
The JDRF Capitol Chapter’s 3rd annual Research Summit in Washington, D.C., on March 9 brought out leaders from the Diabetes Community to talk about everything from the latest in research and technological advances to psychosocial issues for kids and adults with diabetes.
More than 600 people attended this year. Among them was one of our good friends, longtime type 1 and fellow D-blogger Scott Strumello, on the scene along with several other familiar faces from…
Read more »
By
WilD on
September 8, 2012
Happy Saturday! Welcome back to Ask D’Mine, our weekly advice column hosted by veteran type 1, diabetes author and community educator Wil Dubois. This week, Wil offers thoughts on sugar absorption in people with diabetes (not quite what you might think of) and how not every mix of insulin is a good idea
{Got your own questions? Email us at AskDMine@diabetesmine.com}
Valeri, type 2 from Texas, writes: I was diagnosed with type 2 diabetes two years…
Read more »
Participating in a marathon is a pretty amazing feat for anyone, but five people taking part in the 26.2-mile Bank of America Chicago Marathon on Oct. 7 share something that makes this amazing feat extra special: all of them were formerly dependent on insulin, but have had an islet cell transplant and are now living their lives diabetes-free!
Islet cell transplantation is what connects the five together as members of the athletic team Cellmates On The…
Read more »
Diabetes research with mice. Right. We’re never sure when humans will be able to oust the mouse. When fellow D-blogger and journalist Mike Hoskins discovered an interesting study right in his own backyard, he headed straight behind the scenes to get the scoop for us:
Special to the ‘Mine by Mike Hoskins
Once again, some diabetes research news crossed my inbox and made my eyes roll: “Researchers find beta cell stress could trigger the…
Read more »
We were familiar with the company ViaCyte through its former identity as NovoCell, when we reported that they’d managed to successfully control diabetes in mice using embryonic stem cells back in 2008.
Last year, they changed their name, but their two-part mission remained the same: first, to create fully functioning beta cells (the specific kind of islet cells that make insulin and amylin) from embryonic stem cells, and then to find a way to combat…
Read more »
